| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO And Head Of R&D
1 company
Prasad Suyash is a CMO And Head Of R&D at Taysha Gene Therapies, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | TSHA Taysha Gene Therapies, Inc. | CMO And Head Of R&D | Sell | 12,861 | $3.70 | $47,649.79 | -1.2% | -45.5% | -82.5% | |
| Jul 1, 2022 | TSHA Taysha Gene Therapies, Inc. | CMO And Head Of R&D | Sell | 50,139 | $3.65 | $183,080.87 | -2.9% | -41.4% | -80.8% | |
| Jul 1, 2021 | TSHA Taysha Gene Therapies, Inc. | CMO And Head Of R&D | Sell | 79,000 | $22.63 | $1,787,935.64 | -1.8% | -8.9% | -83.6% |